At 48 to 96 hours , the primary outcome occurred in 18.4 % of patients who continued ACEI/ARB compared with 10.9 % of the patients who held ACEI/ARB ( hazard ratio 0.59 , 95 % CI 0.30-1 .19 , P = .16 ) .